16 results
8-K
EX-3.1
RNXT
RenovoRx Inc
8 Sep 23
Amendments to Articles of Incorporation or Bylaws
7:41pm
as a director, such nominee would be in compliance, and will continue to comply, with the Corporation’s corporate governance, conflict of interest
8-K
EX-10.1
RNXT
RenovoRx Inc
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
of counsel that there is an actual conflict of interest that prevents the counsel selected by the Company from representing both the Company (or another
8-K
EX-10.1
j2p2 drl39u
19 Sep 22
RenovoRx Appoints Angela Gill Nelms as Chief Operating Officer
8:45am
DEF 14A
re1jb
29 Apr 22
Definitive proxy
4:06pm
10-Q
EX-10.4
xn0ejfh0jm66qj0ol
15 Nov 21
Quarterly report
12:00am
S-1/A
EX-1.1
030fke3h
5 Aug 21
IPO registration (amended)
5:29pm
S-1/A
EX-10.7
8wve2pd0ppjl
5 Aug 21
IPO registration (amended)
5:29pm
S-1
EX-10.2
qgmlr
21 Jul 21
IPO registration
5:15pm
S-1
EX-10.4
pbxeru5inf976b7e
21 Jul 21
IPO registration
5:15pm
S-1
EX-10.7
vp14gt92
21 Jul 21
IPO registration
5:15pm
DRS/A
EX-10.4
5yr6b
12 May 21
Draft registration statement (amended)
12:00am
DRS/A
EX-10.2
15341y yhoqh0b
12 May 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next